Document Type
Article
Publication Date
8-24-2018
JAX Source
Genome Biol 2018 Aug 24; 19(1):123
Volume
19
Issue
1
First Page
123
Last Page
123
ISSN
1474-760X
PMID
30143034
DOI
https://doi.org/10.1186/s13059-018-1501-6
Abstract
BACKGROUND: Lung cancer is the leading cancer diagnosis worldwide and the number one cause of cancer deaths. Exposure to cigarette smoke, the primary risk factor in lung cancer, reduces epithelial barrier integrity and increases susceptibility to infections. Herein, we hypothesize that somatic mutations together with cigarette smoke generate a dysbiotic microbiota that is associated with lung carcinogenesis. Using lung tissue from 33 controls and 143 cancer cases, we conduct 16S ribosomal RNA (rRNA) bacterial gene sequencing, with RNA-sequencing data from lung cancer cases in The Cancer Genome Atlas serving as the validation cohort.
RESULTS: Overall, we demonstrate a lower alpha diversity in normal lung as compared to non-tumor adjacent or tumor tissue. In squamous cell carcinoma specifically, a separate group of taxa are identified, in which Acidovorax is enriched in smokers. Acidovorax temporans is identified within tumor sections by fluorescent in situ hybridization and confirmed by two separate 16S rRNA strategies. Further, these taxa, including Acidovorax, exhibit higher abundance among the subset of squamous cell carcinoma cases with TP53 mutations, an association not seen in adenocarcinomas.
CONCLUSIONS: The results of this comprehensive study show both microbiome-gene and microbiome-exposure interactions in squamous cell carcinoma lung cancer tissue. Specifically, tumors harboring TP53 mutations, which can impair epithelial function, have a unique bacterial consortium that is higher in relative abundance in smoking-associated tumors of this type. Given the significant need for clinical diagnostic tools in lung cancer, this study may provide novel biomarkers for early detection.
Recommended Citation
Greathouse K,
White J,
Vargas A,
Bliskovsky V,
Beck J,
von Muhlinen N,
Polley E,
Bowman E,
Khan M,
Robles A,
Cooks T,
Ryan B,
Padgett N,
Dzutsev A,
Trinchieri G,
Pineda M,
Bilke S,
Meltzer P,
Hokenstad A,
Stickrod T,
Walther-Antonio M,
Earl J,
Mell J,
Krol J,
Balashov S,
Bhat A,
Ehrlich G,
Valm A,
Deming C,
Conlan S,
Oh J,
Segre J,
Harris C.
Interaction between the microbiome and TP53 in human lung cancer. Genome Biol 2018 Aug 24; 19(1):123
Comments
This open access article is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/)